Evidence map›Paper›PMID 35792565›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?

Alena E Kopytova, Tatiana S Usenko, Galina V Baydakova, Mikhail A Nikolaev, Konstantin A Senkevich, Artem D Izyumchenko, Alexandr A Tyurin, Irina V Miliukhina, Anton K Emelyanov, Ekaterina Y Zakharova and 1 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. p.N370SInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Biochemical Characteristics of iPSC-Derived Dopaminergic Neurons from N370SInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Alena E KopytovaPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.
Tatiana S UsenkoPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.
Galina V BaydakovaFederal State Budgetary Institution "Research Centre for Medical Genetics", Moscow, Russia.
Mikhail A NikolaevPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.ORCID 0000-0002-1952-4678
Konstantin A SenkevichFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
Artem D IzyumchenkoPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.
Alexandr A TyurinFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
Irina V MiliukhinaFirst Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia.
Anton K EmelyanovPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.
Ekaterina Y ZakharovaFederal State Budgetary Institution "Research Centre for Medical Genetics", Moscow, Russia.
Sofya N PchelinaPetersburg Nuclear Physics Institute named by B.P. Konstantinov of National Research Centre "Kurchatov Institute", Gatchina, Russia.ORCID 0000-0001-7431-6014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gaucher DiseaseParkinson Diseasealpha-SynucleinBiomarkersGlucosylceramidaseHumansMutationalpha-SynucleinBiomarkersGlucosylceramidase

Identifiers

PMID35792565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.